Biotechnology News and Research

RSS

DNA-binding fluorescent dyes evaluate cytotoxicity in real-time during screening

High throughput screening of compounds in live cells is a powerful approach for discovering new drugs, but the potential for cell toxicity must be considered.

31 May 2014

New article explores why women still lag behind career advancement

Women have accounted for half the students in U.S. medical schools for nearly two decades, but as professors, deans, and department chairs in medical schools their numbers still lag far behind those of men.

30 May 2014

New powerful tool helps identify disease-causing mutations in families

Scientists at the University of Utah (U of U), the University of Texas MD Anderson Cancer Center in Houston and colleagues have developed a powerful tool called pVAAST that combines linkage analysis with case control association to help researchers and clinicians identify disease-causing mutations in families faster and more precisely than ever before.

30 May 2014

RBCC’s BiO Assay wins grant from CASIS for Biological Research in Microgravity

The BiO Assay, a 3D Bioprinting technology being promoted around the world by the joint venture of Rainbow Coral Corp. (OTCBB: RBCC) and Nano3D Biosciences (n3D), has been awarded a research grant from the Center for Advancement of Science in Space (CASIS)—the sole manager of the International Space Station U.S. National Laboratory.

29 May 2014

TPP wins $500,000 grant from Biogen Idec to help students start and run own businesses

The Biogen Idec Foundation has awarded a $500,000 grant to The Possible Project (TPP), a non-profit organization that teaches high school students how to start and run their own businesses through a tailored curriculum, and access to technology and to mentors from the local business community.

29 May 2014

Patrys reports positive results from PAT-SM6 clinical trial in patients with multiple myeloma

Patrys Limited, a clinical stage biotechnology company, is pleased to announce the clinical results from a patient treated with PAT-SM6 in combination with other marketed multiple myeloma drugs.

28 May 2014

BioTime receives ISO 13485:2003 certification for development of BioTime HyStem hydrogels

BioTime, Inc. today announced that it has received ISO 13485:2003 certification from BSI (British Standards Institution) for design, development, manufacture, and distribution of BioTime HyStem® hydrogels for cell delivery applications.

28 May 2014

Polyplus-transfection introduces FectoPRO transfection reagent

Polyplus-transfection SA, a privately-held company specializing in the development of innovative solutions for transfection, today announces the launch of FectoPRO, the latest optimised transfection reagent in their product portfolio. FectoPRO has been designed for high yields in medium and large-scale production of proteins and antibodies in mammalian cells.

28 May 2014

Transgenomic signs license with Dana-Farber to develop multiplexed ICE COLD-PCR technology

Transgenomic, Inc., a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through advanced diagnostic tests and clinical and research services, today announced that it has signed a license with the Dana-Farber Cancer Institute for worldwide rights to develop and commercialize multiplexed versions of its ICE COLD-PCRTM technology (MX ICE COLD-PCR).

28 May 2014

Researchers recreate human lung in miniature with volume of half cubic centimeter

What medications can be used to treat lung cancer, and how effective are they? Until now, drug companies have had to rely on animal testing to find out. But in the future, a new 3D model lung is set to achieve more precise results and ultimately minimize - or even completely replace - animal testing. From June 23-26, researchers will be presenting their new model at the BIO International Convention in San Diego, California (Germany Pavilion, Booth 4513-03).

28 May 2014

arGEN-X collaborates with Bayer Pharma for development of therapeutic antibodies

arGEN-X, a clinical-stage biopharmaceutical company focused on creating and developing differentiated therapeutic antibodies for the treatment of cancer and severe autoimmune diseases, announced today the initiation of a collaboration with Bayer Pharma AG (Bayer), leveraging arGEN-X's SIMPLE Antibody™ technology for the discovery and development of therapeutic antibodies.

28 May 2014

Study identifies role of additive monosodium glutamate in obesity and liver disease

The commonly used food additive monosodium glutamate (MSG) has been linked to obesity and disorders associated with the metabolic syndrome including progressive liver disease.

28 May 2014

Inovio announces positive results on DNA-based monoclonal antibody therapy targeting CHIKV

Inovio Pharmaceuticals, Inc. announced today that its novel DNA-based therapeutic monoclonal antibody targeting Chikungunya virus (CHIKV) completely protected mice from a lethal CHIKV challenge.

27 May 2014

Research to better understand cell defect that contributes to cancer

A research team from Plymouth University Peninsula Schools of Medicine and Dentistry has received funding from the Biotechnology and Biological Sciences Research Council for research to better understand a cell defect that contributes to diseases such as cancer.

26 May 2014

Visual cortex uses information gleaned from ears as well as eyes

Scientists studying brain process involved in sight have found the visual cortex also uses information gleaned from the ears as well as the eyes when viewing the world.

26 May 2014

New fluorescent molecule paves way for easier and higher quality imaging of cells

Like our own bodies, cells have their own skeletons called 'cytoskeletons' and are made of proteins instead of bones.

26 May 2014

Study: Sufficient copies of SMN1 gene extend survival in animals with spinal muscular atrophy

To make up for insufficient amounts of SMN protein, the cause of the inherited neuromuscular disease spinal muscular atrophy (SMA), researchers have successfully delivered a replacement SMN1 gene directly to the spinal cords of animal models of SMA.

23 May 2014

NCCN receives $2M grant to evaluate effectiveness of volasertib in treatment of hematologic malignancies

The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) has been awarded a $2-million grant from Boehringer Ingelheim Pharmaceuticals, Inc.

23 May 2014

EMA grants Advanced Therapy Medicinal Product classification for TxCell's Col-Treg

TxCell SA, a biotechnology company developing innovative, personalized cell-based immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today that Col-Treg, its second therapeutic candidate from its ASTrIA platform, has been granted Advanced Therapy Medicinal Product (ATMP) classification by the Committee for Advanced Therapies (CAT) of the European Medicines Agency.

22 May 2014

Benefits of using VACUSAFE Laboratory Aspiration System for cell culture applications

INTEGRA has published a new video testimonial in which researchers at the Institute for Clinical Chemistry at the Technical University of Munich describe the benefits of using the VACUSAFE Laboratory Aspiration System to provide simple, reliable and safe aspiration of cell culture supernatents.

From INTEGRA Biosciences 22 May 2014

Biotechnology News and Research

DNA-binding fluorescent dyes evaluate cytotoxicity in real-time during screening

New article explores why women still lag behind career advancement

New powerful tool helps identify disease-causing mutations in families

RBCC’s BiO Assay wins grant from CASIS for Biological Research in Microgravity

TPP wins $500,000 grant from Biogen Idec to help students start and run own businesses

Patrys reports positive results from PAT-SM6 clinical trial in patients with multiple myeloma

BioTime receives ISO 13485:2003 certification for development of BioTime HyStem hydrogels

Polyplus-transfection introduces FectoPRO transfection reagent

Transgenomic signs license with Dana-Farber to develop multiplexed ICE COLD-PCR technology

Researchers recreate human lung in miniature with volume of half cubic centimeter

arGEN-X collaborates with Bayer Pharma for development of therapeutic antibodies

Study identifies role of additive monosodium glutamate in obesity and liver disease

Inovio announces positive results on DNA-based monoclonal antibody therapy targeting CHIKV

Research to better understand cell defect that contributes to cancer

Visual cortex uses information gleaned from ears as well as eyes

New fluorescent molecule paves way for easier and higher quality imaging of cells

Study: Sufficient copies of SMN1 gene extend survival in animals with spinal muscular atrophy

NCCN receives $2M grant to evaluate effectiveness of volasertib in treatment of hematologic malignancies

EMA grants Advanced Therapy Medicinal Product classification for TxCell's Col-Treg

Benefits of using VACUSAFE Laboratory Aspiration System for cell culture applications

Event guide: 3rd IMPACCT Real World Evidence Summit Europe eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News